With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting TGFb Pathway Dependencies in Group 3 Medullobastoma||University of California San Francisco / Zulekha Qadeer, PhD||Young Investigator Grants||2019||California|
|Investigating phase separated condensates in FPD to MDS/AML progression||Broad Institute / Zuzana Tothova, MD/PhD||RUNX1 Early Career Investigator Grants||2019||Massachusetts|
|Harmonizing Data Sharing Efforts towards a Federated Data Model||University of California at Santa Cruz / Olena M. Vaske, PhD & David Haussler, PhD||Crazy 8 Initiative||2019||California|
|Platform development for target identification in high risk pediatric leukemias||Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD/PhD||Crazy 8 Initiative||2019||New York|
|Platform development for target identification in high risk pediatric leukemias||St. Jude Children's Research Hospital / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD/PhD||Crazy 8 Initiative||2019||Tennessee|
|Targeted Hyperactivation of PI3K/AKT in B-cell malignancies||Beckman Research Institute of City of Hope / Vishal Khairnar, PhD||Young Investigator Grants||2019||California|
|Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors||University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD||Young Investigator Grants||2019||Ontario|
|Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow||University of Colorado Denver / Siddhartha S. Mitra, PhD||Crazy 8 Initiative||2019||Colorado|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD & David T. Teachey, MD||Innovation Grants||2019||New York|
|Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers||Children's Hospital of Philadelphia / Claudia Zapata, MD||Young Investigator Grants||2019||Pennsylvania|